|
Code
|
0466D
|
|
MA number
|
EU/1/18/1333/002
|
|
Product Form:
|
tbl flm 90 (3x30)x100 mg/300 mg/245 mg (fľ.HDPE)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Merck Sharp & Dohme B.V., Netherland
|
|
Therapeutic Class:
|
42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J05 |
ANTIVIRALS FOR SYSTEMIC USE |
| J05A |
DIRECT ACTING ANTIVIRALS |
| J05AR |
Antivirals for treatment of HIV infections, combinations |
| J05AR24 |
Lamivudine, tenoforvir disoproxil and doravirine |
|
|
Shelf life:
|
30 |
|
Container:
|
bottle HDPE
|
|
Route of admin.:
|
Oral use
|
European Medicines Agency's database
